United States
Covalab |
 |
Antibody Engineering
|
Covalab is a French biotechnology company, specialized in the field of immunotechnology, founded in 1995 by two experts in immunology to support the scientific community.
Our activity is based primarily on the development of polyclonal and monoclonal antibodies, the synthesis of custom peptides as well as the sale of organic products (antibodies, kits, functionalised plates, immunoaffinity columns...). We collaborate with research groups from academic institutions as well as private companies who are the major players in the field of life sciences. OUR PRODUCTS: Today we are able to provide more than 20,000 polyclonal, monoclonal or recombinant antibodies. Directed against specific targets or dedicated to common use (such as detection and isotype or loading control), you can find the product you need for all laboratory techniques (ELISA, immunochemistry, flow cytometry...).
OUR SERVICESThrough our range of services, coupled with over 30 years of knowledge and experience in the field of immunology and antibody engineering, we are able to meet requirements of increasingly complex nature. From a single peptide sequence to the corresponding purified monoclonal antibody, we cover all the steps of an antibody development project.
We are committed to provide the highest quality of custom services and products within the shortest time. Our scientific & commercial staff is always available to guide you in project management and follow-up. |
RELATED LITERATURECovalab - Your partner in immunology
|
||||||||
another CS2 website
©2019 Axxora, LLC.,
